Search This Blog

Thursday, November 7, 2019

Autolus Therapeutics EPS beats by $0.25, misses on revenue

Autolus Therapeutics (NASDAQ:AUTL): Q3 GAAP EPS of -$0.61 beats by $0.25.
Revenue of $0.3M (-3.2% Y/Y) misses by $0.3M.
Cash and equivalents of $229.4M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)